Several case reports show that checkpoint inhibition of T cell subsets using PD-1 blockers reactivates active TB in cancer patients with latent TB (180, 181), which suggest that some of these checkpoints are required to control the immune balance in the GME. This evidence concerns the gene PDCD1 and cancer.